CARM
Carisma Therapeutics Inc.Company Information
- Company Name
- Carisma Therapeutics Inc.
- CIK
- CIK0001485003
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CARM: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CARM
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2025-10-07
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 176,329
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 1,547,384
- Shares outstanding
- 41,788,096
- Ownership
- 3.70%
Earnings Market Reaction
- Filing date
- 2025-11-12
- Price on filing date
- —
- 1-month reaction
- 16.74%
- 3-month reaction
- -8.59%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 3 | 2 | 8 | 18 | 27 | 40 | 57 | 78 | 83 | 76 | 63 | 24 | ||||||
| Marketable Securities Current | - | - | - | - | - | - | - | 0 | 11 | 41 | 76 | 28 | ||||||
| Restricted Cash Current | - | - | - | - | - | - | - | - | - | - | - | 21 | ||||||
| Prepaid Expense And Other Assets Current | 3 | 2 | 3 | 6 | 7 | 10 | 4 | 3 | 3 | 5 | 6 | 3 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | 0 | 0 | 3 | - | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 6 | 4 | 14 | 24 | 34 | 51 | 61 | 80 | 98 | 122 | 145 | 55 | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 0 | 0 | 0 | 4 | 5 | 7 | 8 | 7 | 7 | 8 | 8 | 0 | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 2 | 2 | 2 | 2 | 5 | 2 | 2 | 3 | 3 | 5 | ||||||
| Restricted Cash Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | - | ||||||
| Deferred Finance Costs Noncurrent Net | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | 4 | ||||||
| Assets | 7 | 5 | 16 | 30 | 42 | 59 | 74 | 90 | 107 | 133 | 156 | 72 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Restricted Cash And Cash Equivalents Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Accounts Payable Current | 6 | 5 | 3 | 2 | 2 | 2 | 2 | 4 | 2 | 2 | 5 | 2 | ||||||
| Goodwill | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Accrued Liabilities Current | 1 | 3 | 5 | 7 | 5 | 9 | 5 | 8 | 7 | 10 | 10 | 10 | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Prepaid Expense Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Operating Lease Liability Current | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 3 | 3 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Finance Lease Liability Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Other Liabilities Current | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 7 | 9 | 10 | 16 | 11 | 16 | 13 | 16 | 13 | 18 | 21 | 20 | ||||||
| Deferred Revenue Noncurrent | 0 | 41 | 41 | 41 | 41 | 41 | 45 | 45 | 45 | 45 | 45 | 45 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | ||||||
| Convertible Long Term Notes Payable | - | - | - | - | - | - | - | 0 | 0 | 0 | - | 34 | ||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | ||||||
| Derivative Liabilities Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | - | 6 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Business Combination Contingent Consideration Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Liabilities | 7 | 51 | 53 | 58 | 53 | 59 | 63 | 63 | 60 | 66 | 70 | 107 | ||||||
| Deferred Income Tax Liabilities Net | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Preferred Stock Value | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | - | - | - | - | - | - | - | 0 | 0 | 0 | - | 108 | ||||||
| Contract With Customer Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Additional Paid In Capital | 279 | 279 | 278 | 278 | 277 | 276 | 275 | 272 | 270 | 269 | 269 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -280 | -325 | -315 | -306 | -288 | -275 | -264 | -245 | -224 | -203 | -183 | -158 | ||||||
| Stockholders Equity | -1 | -46 | -37 | -28 | -11 | 0 | 11 | 27 | 46 | 67 | 86 | -143 | ||||||
| Liabilities And Stockholders Equity | 7 | 5 | 16 | 30 | 42 | 59 | 74 | 90 | 107 | 133 | 156 | 72 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | -0 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | - | - | - | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | ||||||
| Minority Interest | - | - | - | - | - | - | - | 0 | 0 | 0 | - | 14 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 100 | 350 | ||||||
| Common Stock Shares Issued | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 41 | 40 | 40 | 40 | 2 | ||||||
| Shares Outstanding | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 41 | 40 | 40 | 40 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCarisma Therapeutics Inc. (CARM) — SEC Financial Statements & Analysis
Carisma Therapeutics Inc. (CARM) is a pharmaceutical preparations company, incorporated in DE. Carisma Therapeutics Inc. trades on OTC as: CARM. Carisma Therapeutics Inc. (CARM)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12. Based on that filing, Carisma Therapeutics Inc. carries a market cap of $11.45M, a P/E ratio of 1.42x, a P/B ratio of -13.21x, a P/S ratio of 16.50x, an enterprise value of $8.67M, and an EV/EBITDA multiple of 0.71x. On profitability, it posts an operating margin of -1985.21%, a net margin of -1894.46%, a Return on Equity (ROE) of -134.11%, and a Return on Assets (ROA) of 33.09%. Per share, it reports EPS of $0.19, diluted EPS of $0.19, free cash flow per share of $-0.54, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -112.61% year-over-year, and EPS growth of -112.54% year-over-year. On the balance sheet, it maintains a current ratio of 0.86x, a quick ratio of 0.41x, working capital of $-942.00K, a debt-to-equity ratio of -8.56x, a debt ratio of 1.13, an interest coverage ratio of 37.66x, free cash flow of $-22.41M (TTM), and net debt of $-2.78M. Figures sourced from SEC EDGAR.
- Market Cap
- $11.45M
- P/E TTM
- 1.42x
- EPS TTM
- $0.19
- P/B TTM
- -13.21x
- ROE TTM
- -134.11%
- ROA TTM
- 33.09%
- Debt To Equity
- -8.56x
- Free Cash Flow TTM
- $-22.41M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Carisma Therapeutics Inc. in?
Carisma Therapeutics Inc. (CARM) operates in the Pharmaceutical Preparations industry.
What exchange does CARM trade on?
Carisma Therapeutics Inc. (CARM) trades on the OTC.
Where is Carisma Therapeutics Inc. incorporated?
Carisma Therapeutics Inc. is incorporated in DE.
When was Carisma Therapeutics Inc. (CARM)'s most recent SEC filing?
Carisma Therapeutics Inc. (CARM)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-12.
What is CARM's market cap?
Carisma Therapeutics Inc. (CARM) has a market capitalization of $11.45M as of 2025-09-30.
What is CARM's P/E ratio?
Carisma Therapeutics Inc. (CARM)'s trailing twelve month P/E ratio is 1.42x as of 2025-09-30.
What is CARM's EPS (earnings per share)?
Carisma Therapeutics Inc. (CARM)'s trailing twelve month EPS is $0.19 as of 2025-09-30.
What is CARM's ROE (return on equity)?
Carisma Therapeutics Inc. (CARM)'s trailing twelve month Return on Equity (ROE) is -134.11% as of 2025-09-30.
What is CARM's ROA (return on assets)?
Carisma Therapeutics Inc. (CARM)'s trailing twelve month Return on Assets (ROA) is 33.09% as of 2025-09-30.
What is CARM's EV/EBITDA?
Carisma Therapeutics Inc. (CARM)'s trailing twelve month EV/EBITDA is 0.71x as of 2025-09-30.